Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility, efficacy and safety of intravenous
and oral antiepileptic treatment with levetiracetam in patients with primary brain tumors and
symptomatic epilepsy in the period of neurosurgical intervention.